MIP-1alpha, human recombinant

Yes

N/A

N/A

6348

CCL3

Human

P10147

1 year

-20°C

≥98%

E. coli

7.8 kDa

Blue ice

MIP-1 alpha

recombinants

1.0-10 ng/ml.

Lyophilized protein

Recombinants or rec. proteins

Centrifuge the vial prior to opening.

For Research Use Only! Not to be used in humans

Recruits and activates polymorphonuclear leukocytes

Sterile filtered and then lyophilized with no additives

Reconstitute in H₂O to a concentration of 0.1-1.0 mg/ml. The solution can be diluted into other aqueous buffers

Activity was determined by its ability to chemoattract human monocytes using a concentration range of 1.0-10 ng/ml.

Small inducible cytokine A3, CCL3, Macrophage inflammatory protein 1-α, MIP-1-α, Tonsillar lymphocyte LD78 α protein, G0/G1 switch regulatory protein 19-1, G0S19-1 protein, SIS-β, PAT 464,1, chemokine (C-C motif) ligand 3, MIP1A, SCYA3, G0S19-1, LD78α, TY-5, SIS-α, Heparin-binding chemotaxis protein, L2G25B,

Small inducible cytokine A3, CCL3, Macrophage inflammatory protein 1-α, MIP-1-α, Tonsillar lymphocyte LD78 α protein, G0/G1 switch regulatory protein 19-1, G0S19-1 protein, SIS-β, PAT 464,1, chemokine (C-C motif) ligand 3, MIP1A, SCYA3, G0S19-1, LD78α, TY-5, SIS-α, Heparin-binding chemotaxis protein, L2G25B,

Human proteins, cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies. Modern humans (Homo sapiens, primarily ssp. Homo sapiens sapiens). Depending on the epitopes used human ELISA kits can be cross reactive to many other species. Mainly analyzed are human serum, plasma, urine, saliva, human cell culture supernatants and biological samples.